Loading clinical trials...
Loading clinical trials...
Effects of Simethicone and Vivatlac Baby in Infantile Colic
Open trial with two parallel arms, assessing the effects of Simethicone and Vivatlac Baby in babies diagnosed for infantile colic.
Babies aged 3 to 6 weeks will be diagnosed for infantile colic using the Wessel's criteria. Study design will be open label with two parallel arms (Simethicone and Vivatlac Baby). Vivatlac Baby is a synbiotic product containing probiotic bacteria (six lactobacilli and 3 bifidobacteria). Effects of treatments on crying behavior will be assessed by using parental 24h paper diaries.
Age
0 - 0 years
Sex
ALL
Healthy Volunteers
No
GP Practice Pro Familia
Koziegłowy, Poland
Medical University in Poznań
Poznan, Poland
Start Date
April 16, 2020
Primary Completion Date
June 30, 2020
Completion Date
June 30, 2020
Last Updated
November 22, 2023
87
ACTUAL participants
Simethicone Solution
DRUG
Vivatlac Baby
DIETARY_SUPPLEMENT
Lead Sponsor
The President Stanisław Wojciechowski State University of Applied Sciences in Kalisz
NCT05432479
NCT06385054
NCT04632888
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions